Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Amortization of Deferred Charges (2022 - 2023)

Historic Amortization of Deferred Charges for Adma Biologics (ADMA) over the last 3 years, with Q4 2023 value amounting to $877000.0.

  • Adma Biologics' Amortization of Deferred Charges fell 996.52% to $877000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was $877000.0, marking a year-over-year decrease of 7770.19%. This contributed to the annual value of $3.8 million for FY2023, which is 2795.2% up from last year.
  • Adma Biologics' Amortization of Deferred Charges amounted to $877000.0 in Q4 2023, which was down 996.52% from $993000.0 recorded in Q3 2023.
  • In the past 5 years, Adma Biologics' Amortization of Deferred Charges ranged from a high of $1.0 million in Q2 2022 and a low of $877000.0 during Q4 2023